The drugmaker has been seeking to bolster its pipeline as its top-selling drug, Keytruda, is set to lose patent protection.
Source link
Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns
Date:
More like thisRelated
Woman accused of holding stepson captive over 20 years in abusive conditions to go to trial in February
The case of a Connecticut woman accused of holding...
LeBron James is set to open his 24th season when the 76ers visit Madison Square Garden
NEW YORK —There was a plausible scenario where LeBron...
Tulsa King: It Wasn’t an Accident! [Episode 2 Preview, Pictures]
Tulsa King's most unexpected tragedy may just be a result of...